(HKEX: 02162)�("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed�IL-4Ra ...
A laryngologist explains the surprising causes of chronic throat clearing, including silent reflux, allergies and muscle memory. Learn expert strategies to break the cycle and protect vocal health.
Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...
A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.
Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...
A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...
Learn more about whether Corcept Therapeutics Incorporated or Novartis AG is a better investment based on AAII's A+ Investor ...
Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...
The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...
The study results demonstrate the ability to improve the sense of smell with noninvasive devices in different types of users.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback